Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**TBC1 domain family member 29, pseudogene (TBC1D29P)** is a human genetic locus classified as a pseudogene, meaning it resembles a protein-coding gene but lacks functional coding capacity and is not believed to produce a biologically active protein product[1][2][3][4][5][8][9][10]. TBC1D29P is related by sequence similarity to the TBC1 domain family but does not possess a functional role as an enzyme, transporter, receptor, or other druggable protein and is not considered a therapeutic target.\n\nEssential context and supporting details:\n- **Canonical name, abbreviation, aliases:** The gene is officially designated *TBC1 domain family member 29, pseudogene* (TBC1D29P), with common aliases \"TBC1D29,\" \"DKFZP434O047,\" and \"Putative TBC1 domain family member 29\"[1][2][3][4][5].\n- **Molecular classification:** Listed as a pseudogene, it lacks the features and activity typical of protein-coding genes; does not belong to any classical receptor, enzyme, transporter, or transcription factor families[1][2][3][4][10].\n- **Function:** No confirmed biological function, enzyme, or receptor activity has been ascribed to TBC1D29P[2][3][10].\n- **Disease role:** No association with human disease, therapeutic targeting, or biomarker use is documented[2][3][8][10].\n- **Drug interactions/mechanisms:** No known drugs interact with TBC1D29P, nor have any mechanisms of action been described for therapeutics targeting this pseudogene[2][3][10].\n- **Correction of premise:** TBC1D29P is not a classical pharmacological or therapeutic target; it is a non-coding genomic element, so entries like function, interacting drugs, mechanism of action, biomarker status, and safety concerns are not applicable.\n\nIf you are seeking a functional or druggable target within the TBC1 domain family, another family member such as **TBC1D1** or **TBC1D4** would be more relevant[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TBC1 domain family member 29, pseudogene (TBC1D29P).